Receptor–Ligand Protein Pairs for Neutralization and Inhibition Assays

Receptor–ligand protein pairs for neutralization and inhibition assays help researchers build competitive ELISA, SPR, BLI and proximity-assay workflows for evaluating antibodies, Fc fusions, peptides and other blocking molecules. Beta LifeScience offers catalog-listed receptors, ligands, immune-checkpoint proteins, cytokines and biotinylated formats, with semi-custom and full-custom production available when a project requires coordinated constructs, alternative tags or specialized variants.

Planning a receptor–ligand inhibition assay?

Compare catalog-listed immune-checkpoint proteins, cytokines, receptors, ligands and biotinylated formats for binding and inhibition assay development.

Featured Receptor–Ligand Protein Pair Options

The following examples illustrate catalog routes for immune-checkpoint, co-stimulatory and cytokine-receptor interactions. Review each current product page for the selected construct, pack size and available documentation. The technical team can also confirm availability, lead time and project-specific requirements before ordering. Pack-size-specific SKUs may include an additional quantity suffix.

These products are purchasing examples rather than preassembled assay kits. Numerical EC50 or affinity values on individual pages apply only to the documented test conditions. Researchers should confirm that the two selected catalog formats are compatible with the planned immobilization, detection reagents and inhibitor mechanism.

Need a matched receptor–ligand format?

Share both target sequences, species, assay platform, preferred capture orientation, tags, quantities and QC requirements. The technical team can compare catalog options and evaluate coordinated semi-custom or custom production.

Request Product Matching and a Quotation

What an Inhibition Assay Needs to Measure

A protein-based inhibition assay should measure a reduction in receptor–ligand binding attributable to the test molecule. A practical design includes:

• one immobilized interaction partner;
• one soluble or detectably labeled partner;
• the antibody, inhibitor or competitor under evaluation;
• a no-inhibitor binding control;
• a background control lacking one interaction partner; and
• an appropriate concentration series.

Early screening may rank candidates at several concentrations, while lead characterization may require a full curve and another assay format. Protein-based inhibition demonstrates disruption of a defined interaction; cell-based testing is needed when functional signaling is the objective.

Select the Pair Before Choosing the Platform

Confirm the biological interaction

Start with the exact receptor and ligand names, species and isoforms. PD-1 can interact with PD-L1 and PD-L2, while TNF-α can signal through TNFR1 and TNFR2. Record the accession, residue range and mutations, and confirm that the construct contains the relevant binding domain.

Align species and sequence boundaries

Use matched-species partners unless a cross-species interaction is intentional. Soluble extracellular domains are common for membrane receptors, but each construct must retain the binding region. Align equivalent domains for coordinated comparisons.

Compare expression systems

Mammalian expression can be valuable for extracellular proteins that depend on disulfide bonds, glycosylation or complex folding. Other hosts may suit selected cytokines or simpler constructs. Use the expression-host selection guide and document host differences across the pair.

Choose Tags and Assay Orientation Together

Tags determine how each protein is captured or detected and should be selected with the assay architecture.

The protein tag selection guide provides additional purchasing context for His, Fc, GST, FLAG, Avi and other formats. Fc tags can support multivalent presentation but require Fc-matched controls. Using His tags on both proteins may complicate selective detection; one practical option is a biotinylated capture partner with a differently tagged soluble partner.

Assay Formats for Neutralization and Inhibition

Competitive ELISA

Competitive ELISA immobilizes one partner, detects the second and measures signal reduction after adding the test molecule. Keep receptor and ligand concentrations below saturation so inhibition remains measurable and the assay window is not compressed.

SPR and BLI

SPR and BLI can support competition, blocking or sequential-binding studies. Immobilization density, mass transport, avidity and regeneration influence results, so report the construct, tag and capture orientation with inhibitory or kinetic values.

TR-FRET and proximity assays

Homogeneous proximity formats support miniaturized screening when tags place the donor and acceptor within a useful distance. See the TR-FRET protein selection guide for format considerations.

Cell-based neutralization

Cell-based assays can measure reporter activity, receptor phosphorylation, proliferation or cytokine release. They add functional context after protein-based studies identify candidates that disrupt the direct interaction.

Build Controls Into the Purchase List

A complete order often needs more than the receptor and ligand. Consider adding:

1. A non-blocking or isotype control antibody
2. A known blocking control where appropriate and available
3. An unrelated protein carrying the same tag
4. Fc-only or tag-matched controls for Fc-tagged constructs
5. Detection-reagent-only and no-ligand controls
6. An ortholog or related-family protein when selectivity matters

Controls help distinguish genuine disruption from tag recognition, nonspecific adsorption, steric interference or detection-system effects. They also make it easier to interpret inhibitors that bind one partner but do not block the receptor–ligand interface.

Choose a Catalog, Semi-Custom or Custom Route

Semi-custom and custom services are subject to technical feasibility. Submitting both interaction partners together helps the technical team review sequence boundaries, expression systems, tag compatibility, formulation and QC before quotation.

Need a compatible receptor–ligand pair?

Share both targets, species, assay format and preferred tags to request a matched-pair evaluation and quote.

Request a Matched-Pair Evaluation

Why Order Receptor–Ligand Proteins from Beta LifeScience?

The catalog includes recombinant proteins across multiple species, expression systems and tag formats, including immune-checkpoint proteins, cytokines, receptors, ligands and biotinylated proteins. Researchers can purchase compatible catalog products for initial assay development or request technical evaluation when the two interaction partners require aligned constructs. Semi-custom support may be suitable for alternative tags, buffer exchange, higher concentration, specialized packaging, endotoxin requirements or additional QC. Full-custom protein expression can be evaluated for new sequences, domains, isoforms and variants. Submitting both interaction partners together gives the technical team the information needed to assess format compatibility and prepare a project quotation.

Information to Include in a Quote Request

1. Receptor and ligand names, species and accession numbers
2. Required sequence boundaries, isoforms or mutations
3. Test molecule type and expected blocking mechanism
4. ELISA, SPR, BLI, TR-FRET or cell-based assay platform
5. Preferred immobilized and soluble partners
6. Tags, labeling method and detection reagents
7. Required quantities, concentrations and formulations
8. Purity, endotoxin, activity and documentation requirements
9. Delivery schedule and quotation needs

FAQs

Are receptor–ligand protein pairs supplied as assay kits?

The featured products are individual catalog proteins, not preassembled assay kits. Researchers should select compatible partners, controls and detection reagents for the planned configuration.

Which protein should be immobilized?

Immobilize the partner that best fits the capture chemistry and inhibitor mechanism. Compare both orientations during development when steric accessibility or avidity may affect the result.

Does an active product-page result guarantee inhibition-assay performance?

No. It documents activity in the stated product-page configuration. Performance in a new competitive assay depends on the selected partner, concentrations, tags, orientation and test molecule.

Can biotinylated proteins be used in SPR or BLI?

They can be suitable for compatible streptavidin-based surfaces. Confirm the biotinylation method, degree of labeling, tag position and platform requirements before ordering.

Can the technical team evaluate a coordinated receptor–ligand pair?

Yes, catalog matching and semi-custom or custom feasibility can be reviewed when both target sequences, formats, assay requirements and quantities are submitted together.

Can I order both receptor and ligand proteins together?

Yes. When both compatible partners are catalog-listed, review their individual product pages and select the required pack sizes. If the available constructs do not match the planned assay orientation, submit both targets for semi-custom or full-custom technical evaluation.

Conclusion:

Compare available receptor and ligand proteins by species, sequence, expression system, tag and documented activity. For alternative tags, aligned constructs, specialized variants or coordinated production, submit both interaction partners for technical evaluation.

• Browse the Recombinant Protein Catalog
• Review Custom Protein Expression Services
• Request a Custom Matched-Pair Quote